IPCA Laboratories Limited
No trades
Fundamentals and stats
Top segments and regional performance
Last year, the company generated 89.40 B INR, the most of which — 44.62 B INR — came from its top-performing segment, Branded Generics, compared to 37.61 B INR the previous year. The greatest contribution came from India, which accounted for 39.60 B INR last year, with 36.14 B INR the year before.
By source
By country